Acquired von Willebrand Syndrome in IgM Monoclonal Gammopathy as the Presentation of Lymphoplasmacytic Lymphoma

<div>Laboratory response of AVWS after treatment of lymphoplasmacytic lymphoma with carfilzomib, rituximab, and dexamethasone. Arrows indicate cycles of treatment. Treatment resulted in normalization of VWF antigen level (VWF:Ag), VWF activity (VWF:RCo), and factor VIII activity assay (FVIII activity). Normal values are shown in parentheses.</div>

Case Reports in Hematology

fig1

Figure 1

Figure 1: Acquired von Willebrand Syndrome in IgM Monoclonal Gammopathy as the Presentation of Lymphoplasmacytic Lymphoma 